test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PGRProgressive Corp
Recent Activity
New Position
0.36%
$1.015M
4,000 shares@ $253.76 avg price
FCNCAFirst Ctzns Bancshares Inc N
Recent Activity
New Position
0.32%
$920,475
500 shares@ $1840.95 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
0.26%
$737,395
46,116 shares@ $16.0 avg price
ALVAutoliv Inc
Recent Activity
New Position
0.24%
$672,264
7,200 shares@ $93.37 avg price
PRAXPraxis Precision Medicines I
Recent Activity
New Position
0.22%
$630,121
10,951 shares@ $57.55 avg price
KYMRKymera Therapeutics Inc
Recent Activity
New Position
0.21%
$603,126
12,743 shares@ $47.33 avg price
CGONCg Oncology Inc
Recent Activity
New Position
0.21%
$593,644
15,734 shares@ $37.74 avg price
RNAAvidity Biosciences Inc
Recent Activity
New Position
0.2%
$574,309
12,504 shares@ $45.94 avg price
LILi Auto Inc
Recent Activity
New Position
0.2%
$561,735
21,900 shares@ $25.65 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
New Position
0.2%
$559,682
11,085 shares@ $50.5 avg price